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Summary 
The genetic diseases Hutchinson-Gilford progeria 
syndrome (HGPS) and restrictive dermopathy (RD) arise 
from accumulation of farnesylated prelamin A because of 
defects in the lamin A maturation pathway. Both of these 
diseases exhibit symptoms that can be viewed as 
accelerated aging. The mechanism by which accumulation 
of farnesylated prelamin A leads to these accelerated aging 
phenotypes is not understood. Here we present evidence 
that in HGPS and RD fibroblasts, DNA damage 
checkpoints are persistently activated because of the 
compromise in genomic integrity. Inactivation of 
checkpoint kinases Ataxia-telangiectasia-mutated (ATM) 
and ATR (ATM- and Rad3-related) in these patient 
cells can partially overcome their early replication 
arrest. Treatment of patient cells with a protein 
Introduction 
Hutchinson-Gilford progeria syndrome (HGPS) is a severe 
childhood disease characterized by accelerated aging, which is 
caused by a de novo point mutation (1824CrT) in the LMNA 
gene, which encodes lamin A and the splice variant lamin C 
and germ cell-specific lamin C2 (De Sandre-Giovannoli et al., 
2003; Eriksson et al., 2003). These lamins are intermediate 
filament proteins composing the nuclear lamina, a scaffold 
underlying the inner nuclear membrane that structurally 
supports the nucleus and organizes chromatin (Goldman et al., 
2002). The point mutation (1824CrT) of LMNA results in 
defective maturation of lamin A from its precursor prelamin A 
by causing a deletion of 50 amino acids near the C-terminus 
of prelamin A, which contains an endoprotease (Zmpste24) 
cleavage site required for the proteolytic maturation of lamin 
A (Eriksson et al., 2003). Zmpste24 mutation leads to another 
progeroid disorder, restrictive dermopathy (RD), which is 
neonatally lethal (Navarro et al., 2005). Loss of Zmpste24 
activity arrests the processing of prelamin A at a stage similar 
to HGPS, although a unique truncated prelamin A (progerin) 
is accumulated in HGPS cells. Based on our prior elucidation 
of the prelamin A processing pathway (Sinensky et al., 1994b), 
these mutations are predicted to result in accumulation of 
farnesylated and carboxymethylated prelamin A. These two 
diseases have been suggested to be manifestations of the same 
cellular problem to different degrees (Misteli and Scaffidi, 
2005). Although the molecular mechanisms by which theses 
mutations result in premature aging are far from full 
farnesyltransferase inhibitor (FTI) did not result in 
reduction of DNA double-strand breaks and damage 
checkpoint signaling, although the treatment significantly 
reversed the aberrant shape of their nuclei. This suggests 
that DNA damage accumulation and aberrant nuclear 
morphology are independent phenotypes arising from 
prelamin A accumulation in these progeroid syndromes. 
Since DNA damage accumulation is an important 
contributor to the symptoms of HGPS, our results call into 
question the possibility of treatment of HGPS with FTIs 
alone. 
Key words: DNA damage responses, Progeria, Lamin A, 
Farnesyltransferase inhibitor, DNA double-strand breaks, ATR and 
ATM checkpoints 
understanding, Liu et al. recently reported that human 
HGPS fibroblasts and Zmpste24-deficient mouse embryonic 
fibroblasts (MEFs) showed increased DNA damage and repair 
defects (Liu et al., 2005a). In addition, Varela et al. showed that 
Zmpste24 deficiency in mouse elicits the upregulation of p53 
target genes (Varela et al., 2005). These studies suggest that the 
genomic integrity was compromised in HGPS and RD cells 
because of the accumulation of progerin and prelamin A, 
respectively. 
Accumulation of DNA damage might activate DNA damage 
and replication checkpoints, which attenuate cell-cycle 
progression and arrest replication, thereby preventing DNA 
lesions from being converted to inheritable mutations (Li and 
Zou, 2005). Two protein kinases of the phosphoinositide 3­
kinase-like kinase (PIKK) family, Ataxia-telangiectasia­
mutated (ATM) and ATM- and Rad3-related (ATR), play the 
central roles in initiating the damage and replication 
checkpoints (Abraham, 2001; Li and Zou, 2005). ATM is 
activated primarily in response to DNA double-strand breaks 
(DSBs) (Shiloh, 2003), whereas ATR is activated by a broad 
range of DNA damage and replication interference (Abraham, 
2001; Li and Zou, 2005). Upon activation, ATM and ATR 
phosphorylate two major signal-transducing kinases Chk1 and 
Chk2, which in turn regulate downstream targets, such as 
Cdc25A, Cdc25C and p53, to control cell-cycle progression 
and DNA synthesis (Li and Zou, 2005; Sancar et al., 2004). It 
has been reported that in telomere-initiated senescence, a 











damage stress was activated involving ATM, ATR and 
downstream kinases Chk1 and Chk2 (d’Adda di Fagagna et 
al., 2003; von Zglinicki et al., 2005). Kinase inactivation 
experiments showed that this signaling pathway has to be 
maintained in order to keep cells in a senescent state (d’Adda 
di Fagagna et al., 2003; von Zglinicki et al., 2005). DNA 
damage accumulation and responses resulting from repair 
defects might lead to phenotypes associated with premature 
aging and might have causal roles in normal aging (Lombard 
et al., 2005). Furthermore, evidence has been presented that 
progerin expression occurs during the normal aging process 
(Scaffidi and Misteli, 2006). Given the similarities between 
these progeroid syndromes and normal aging, we speculated 
that the same signaling pathway of DNA damage response is 
activated in HGPS and RD cells as in telomere-initiated 
senescence. 
Several recent studies have shown that inhibition of prelamin 
A farnesylation by protein farnesyltransferase inhibitors (FTIs) 
reversed the aberrant nuclear morphology of progeroid cells 
(Capell et al., 2005; Mallampalli et al., 2005; Toth et al., 2005). 
However, the important question as to whether treatment with 
FTIs concurrently restores the genomic integrity in these cells 
remains to be addressed. 
In this study, we report that DNA damage checkpoints were 
constantly activated in HGPS and RD cells because of DNA 
defects. Strikingly, inactivation of ATR and ATM by a specific 
kinase inhibitor or RNA interference (RNAi) partially restored 
DNA replication in HGPS cells. Also importantly, treatment of 
the patient cells with a protein FTI was found to have no effect 
on DNA damage in these cells. 
Results 
Early replication arrest of RD cells and HGPS cells 
Results from our studies (see below) and others (Liu et al., 
2005a; Varela et al., 2005) showed that a considerable amount 
of phosphorylated histone H2AX (y-H2AX), a molecular 
marker for DNA DSBs (Sedelnikova et al., 2002), formed in 
HGPS and RD cells. This indicates that DNA damage 
accumulates in patient cells. To determine the status of DNA 
replication in these cells, a DNA replication assay with 
replicative incorporation of [methyl-3H] thymidine was 
performed. As shown in Fig. 1, DNA synthesis in the HGPS 
and RD cells of passage 11 occurred at rates more than 2-fold 
slower than that in BJ cells, a non-transformed human diploid 
fibroblast cell line. Moreover, replicative capacity was lost at 
passage 15 for RD cells and at passage 21 for HGPS cells (Fig. 
1), in contrast to the more typical replicative behavior of BJ 
cells which exhibit many more passages before undergoing 
replicative senescence (Steinert et al., 2000). This premature 
replicative senescence of the patient cells is consistent with the 
previous reports that the percentage of S-phase cells in 
Zmpste24-deficient MEFs was lower than that in normal MEFs 
(Liu et al., 2005a; Varela et al., 2005). 
Activation of ATM and ATR in RD cells and HGPS cells 
The premature replicative senescence of HGPS and RD cells 
suggested that G1-S and/or intra-S-phase checkpoints were 
probably activated. To test this notion, we assessed the activation 
of ATM and ATR, two central initiators of DNA damage 
checkpoints (McGowan and Russell, 2004), in HGPS and RD 
cells using the method of immunofluorescence microscopy. In 
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Fig. 1. Early replication arrest of HGPS and RD cells. The 
replication assay was performed with [methyl-3H] thymidine labeling 
as described in Materials and Methods. Symbols represent 
radioactivity values as follows: e, BJ cells; 0, HGPS cells; T, RD 
cells. The values were calculated from three independent 
experiments. Error bars represent standard deviations. 
BJ cells, the majority of ATM was homogenously distributed 
in the nucleus (Fig. 2A). The treatment of BJ cells with 
camptothecin (CPT), a radiomimetic agent widely used to 
induce DSBs and activate ATM in cells (Shiloh, 2003), caused 
ATM focus formation in the nuclei (Fig. 2A). Interestingly, a 
very similar pattern of ATM nuclear focus formation was 
observed in HGPS and RD cells even without treatment with 
CPT, suggesting that ATM was activated in these cells (Fig. 2A). 
By contrast, a different pattern of activation was observed for 
ATR in these patient cells. In unstressed BJ cells, ATR was 
mainly localized in cytoplasm, with little or no nuclear staining 
(Fig. 2B). After UV irradiation, a known DNA damaging stress 
that induces ATR activation (Abraham, 2001), ATR translocated 
from cytoplasm into the nucleus. Interestingly, whereas the 
majority of ATR was in the nuclei of untreated RD cells, only 
part of ATR was distributed in the nuclei of HGPS cells and 
formed large foci or aggregates (Fig. 2B). The nuclear 
distribution of ATR in RD and HGPS cells suggests its activation 
in these cells, which is confirmed by the phosphorylation of its 
primary substrate Chk1 (see below). To verify that nuclear 
translocation of checkpoint kinases in the patient cells arises 
from expression of prelamin A, HeLa cells were transfected with 
a plasmid encoding progerin (LAM50) for immunofluorescence 
analysis. As shown in Fig. 2C, the majority of ATR was in 
cytoplasm in HeLa cells transfected with an empty parent vector. 
By contrast, ATR was mainly located in nuclei, forming large 
foci in the HeLa cells transfected with the LAM50-expression 
plasmid. This indicated that the nuclear translocation of 
checkpoint kinases was indeed induced by the presence of 
progerin. Thus, DNA damage in HGPS and RD cells, arising 
from prelamin A accumulation, results in nuclear distribution of 
ATR and ATM, consistent with activation of cell cycle 
checkpoints. 
To confirm the presence of checkpoint response pathways 
in HGPS and RD cells, we next examined the activation of 
downstream signal-transducers Chk1 and Chk2, and the 
effector p53, by assessing their phosphorylation status at 
specific sites (Helt, 2005). As shown in Fig. 3, besides 
phosphorylation of H2AX, phosphorylation of Chk1 (Ser-345), 
Chk2 (Thr-68) and p53 (Ser-15) were all readily detected in 











Fig. 2. Activation of ATM and ATR in HGPS and RD cells. (A) CPT 
treatment was done by incubating the cells with 4 1M camptothecin 
for 1 hour. Cells with or without treatment were fixed with cold 
methanol (–20°C) followed by immunofluorescence microscopy with 
ATM antibody staining. Blue, DAPI; red, ATM. (B) UV treatment 
was performed by irradiating the cells with 20 J/m2 UV. Two hours 
after the treatment, the cells with or without treatment were fixed and 
stained with ATR antibody for immunofluorescence microscopy. 
Blue, DAPI; red, ATR. (C) HeLa cells grown on coverslips were 
transfected with the plasmid for expressing progerin (LAM50) or 
empty parent vector. Twenty-four hours after transfection, the cells 
were irradiated with 20 J/m2 UV or mock treated. After additional 2­
hour culture, the cells were processed for immunofluorescence 
microscopy. Blue, DAPI; green or red, ATR. Photomicrographs were 
taken at 63X magnification. Bar, 50 1m. 
HGPS and RD cells, confirming the activation and signaling of 
checkpoint pathways in these cells. 
Restoration of replication activity by inactivation of ATM 
and ATR 
DNA damage checkpoint responses are complex signaling 
pathways orchestrated by the PIKK family including ATM and 
ATR (Abraham, 2001). Cells with deficient ATM and/or ATR 
are defective in initiating DNA damage-induced cell-cycle 
arrest (Shiloh, 2003). To test whether inactivation of ATM and 
ATR could abolish the premature senescence observed in the 
patient cells, we treated cells with 5 mM caffeine, an ATM and 
ATR inhibitor (Sarkaria et al., 1999), and measured their DNA 
synthesis by [methyl-3H] thymidine labeling. As shown in Fig. 
4A, both ATM and ATR were efficiently knocked down in BJ 
and HGPS cells transfected with ATR and ATM small 
Fig. 3. Phosphorylation of Chk1, Chk2 and p53 in HGPS and RD 
cells. Western blotting was performed as described in Materials and 
Methods. The phosphorylation status of p53 was determined with 
p53 Ser-15 phosphorylation-specific antibody. The total p53 was 
probed as the loading control to ensure that the same amounts of p53 
were loaded for BJ, RD and HGPS cells. In the right panel, [-actin 
was probed to ensure that similar amounts of proteins were loaded 
for the three cell lines. 
Fig. 4. Restoration of replication activity in HGPS cells by 
inactivation of ATM and ATR. (A) Western blotting shows the 
knockdown of ATR and ATM in BJ and HGPS cells by RNAi. [­
actin was used as sample loading control. (B) The replication assay 
was performed with [methyl-3H]-thymidine labeling as described in 
Materials and Methods. BJ cells and HGPS cells used were at 
passage 12. The asterisk indicates a significant difference, P<0.05. 
interfering RNAs (siRNAs). The observation of lower cellular 
levels of ATM and ATR in green fluorescent protein (GFP) 
siRNA-transfected HGPS cells than in corresponding BJ cells 
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Fig. 5. FTI treatment of HGPS and RD cells. (A) Improvement of nuclear shapes of HGPS and RD cells by FTI treatment. The patient cells 
were treated with FTI and prepared for immunofluorescence microscopy as described in Materials and Methods. The nuclei were stained with 
DAPI. Misshapen nuclei are indicated by arrows. Photomicrographs were taken at 63X magnification. Bar, 50 1m. (B) FTI treatment blocked 
farnesylation of prelamin A, but did not change the production of y-H2AX, a molecular marker for DSBs. In the left panel, BJ and HGPS cells 
were lysed in 2X SDS gel loading buffer and probed with the antibody directly against prelamin A. In the right panel, HGPS and RD cells were 
lysed and probed with the antibody for y-H2AX. [-actin was loaded to ensure similar amounts of samples were used for each pair of 
experimental groups. (C) Comet assays were performed with HGPS cells in the presence and absence of FTI as described in Materials and 
Methods. DSBs of 50 randomly chosen cells were quantitated as the percentage of DNA in tail. (D) Phosphorylation of Chk1 and Chk2 in 
HGPS cells with or without FTI treatment. The FTI treatment of BJ and HGPS and western blotting were performed as described in Materials 
and Methods. The phosphorylation statuses of Chk1 at Ser-345 and Chk2 at Thr-68 were determined with corresponding antibodies. [-actin 
was probed as a loading control. (E) Accumulation of y-H2AX in cells expressing prelamin A mutants. HeLa cells were transfected with 
plasmid pEGFP (empty parent vector), pEGFP-LAM50 or pEGFP-LAM50-SSIM, followed by western blot analysis. GAPDH was probed as a 
loading control. 
and ATR in the checkpoint-activated HGPS cells. These 
proteins could be partially resistant to extraction for western 
blot analysis. However, regardless of the basis for the lowered 
levels of ATM and ATR in the controls, a relative knockdown 
by the siRNAs was observed. As shown in Fig. 4B, the 
knockdown significantly increased DNA synthesis in HGPS 
cells, while having no obvious effect on that of the control BJ 
cells. Similar data were produced by treating the cells with 
caffeine (Fig. 4B). These results confirm that DNA damage 
checkpoints were activated in the patient cells, and demonstrate 
that the replicative senescence of these patient cells can be 
reversed by inactivation of checkpoint kinases. 
FTI treatment, a potential therapy for HGPS and RD? 
Recent studies showed that FTI treatment can correct aberrant 
nuclear morphology in HGPS fibroblasts (Capell et al., 2005; 
Mallampalli et al., 2005; Toth et al., 2005) and RD fibroblasts 
(Toth et al., 2005). FTI treatment also ameliorates disease 
phenotypes in Zmpste24-deficient mice (Fong et al., 2006). 
Since DNA damage accumulation is believed to be one of the 
major causes of accelerated aging, cellular senescence and 
normal aging (d’Adda di Fagagna et al., 2003; Gorbunova and 
Seluanov, 2005; Kirkwood, 2005; Lees-Miller, 2005; Lombard 
et al., 2005; Misteli and Scaffidi, 2005; von Zglinicki et al., 
2005), it is of great interest to test whether FTIs can also reduce 
the accumulated DNA damage in these cells. As shown in Fig. 
5A, treatment of HGPS and RD fibroblasts of passage 15 with 
L-744832, a potent FTI (Capell et al., 2005), significantly 
reduced the percentage of cells with misshapen nuclei (from 
47% to 11% for RD cells, P<0.005; from 33% to 6% for HGPS 
cells, P<0.001). The misshapen nuclei were defined as nuclei 
with blebs, folds or gross irregularities in shape (Toth et al., 
2005), and the counting was performed by two observers who 
randomly chose 200 cells from each experimental group. This 
result confirms that FTI treatment can normalize the nuclear 
morphology of the patient cells. Consistently, FTI treatment of 
BJ and HGPS fibroblasts caused accumulation of prelamin A in 
these cells as analyzed by western blotting (Fig. 5B) with 
prelamin A-specific antibody (Sinensky et al., 1994a), 
demonstrating the efficacy of the FTI in blocking farnesylation 
in cells. By contrast, however, no substantial reduction of DSBs 
was detected in HGPS and RD cells after FTI treatment, as 
evidenced by the amount of y-H2AX analyzed by western 
blotting (Fig. 5B). The same HGPS cells were also subjected to 
single cell gel (SCG) electrophoresis or comet assays that 
directly measured the DSBs in cells. As shown in Fig. 5C, there 
was no substantial difference in the amount of DNA damage 
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addition, ATM and ATR damage checkpoint signaling was also 
examined. As shown in Fig. 5D, both the checkpoint substrates, 
Chk1 and Chk2, of ATR and ATM, were well phosphorylated 
in FTI treated and untreated HGPS cells, indicating their 
activation. Importantly, the phosphorylation was equally 
efficient in the cells with or without FTI treatment. These 
observations indicated that FTI treatment was unable to reduce 
the accumulated DNA damage in these cells despite its capacity 
to improve the nuclear morphology. 
To further confirm the results, pEGFP-LAM50 and 
pEGFP-LAM50-SIIM plasmid constructs, respectively, were 
transfected into HeLa cells. pEGFP-LAM50-SIIM is a 
construct for expression of the LAM50 with a mutation at its 
farnesylation site, making the progerin prenylation­
incompetent (Capell et al., 2005). Unlike FTI treatment, which 
might not be able to completely abolish the farnesylation of 
progerin, expression of pEGFP-LAM50-SIIM produces only 
the unfarnesylated LAM50. As shown in Fig. 5E, the 
expression of LAM50 and prenylation-incompetent LAM50­
SSIM in HeLa cells induced similar levels of y-H2AX 
accumulation, indicating that farnesylation had no substantial 
effect on the cellular DNA damage accumulation induced by 
progerin. This is consistent with the above results obtained 
with HGPS cells. Our results also suggested that DNA damage 
accumulation and misshapen nuclei are perhaps two 
independent phenotypes produced by prelamin A accumulation 
in HGPS and RD. 
Discussion 
DNA damage is believed to contribute to both aging and 
cellular senescence (Lombard et al., 2005) which has been 
regarded as a permanently maintained DNA damage response 
state (von Zglinicki et al., 2005). Defects in several DNA repair 
proteins lead to DNA damage accumulation and damage 
responses, which cause phenotypes reminiscent of premature 
aging (Lombard et al., 2005). As there is no evidence for any 
mutations in DNA repair genes in HGPS and RD cells, we, and 
others, hypothesize that prelamin A accumulation affects DNA 
repair in these syndromes. In this study, we present direct 
evidence that DNA damage checkpoints were constantly 
activated in HGPS and RD cells because of accumulated DNA 
damage. We also demonstrated that the subcellular distribution 
of checkpoint kinases ATM and ATR might be used as an 
indicator for their activation in vivo. Inactive ATM is 
homogenously distributed in the nucleus, whereas nuclear 
focus formation of ATM indicates its activation. In unstressed 
cells, ATR is mainly localized in cytosol, but translocates into 
the nucleus upon DNA-damaging stress such as UV irradiation. 
Our finding is contradictory to that of Manju et al., who 
recently reported that ATR was normally localized in the 
nucleus (Manju et al., 2006). The explanation for this 
discrepancy might lie in the fact that Flag-ATR was ectopically 
expressed in cells in the Manju et al. study, whereas we used 
normal cells and stained endogenous ATR directly. The 
expression of exogenous proteins probably induces stress to the 
cells, which might cause the translocation of ATR from cytosol 
to the nucleus. In the present study, activation of ATR and ATM 
in the patient cells as evidenced by immunofluorescence 
determination was confirmed by the phosphorylation of their 
downstream substrates Chk1, Chk2 and p53 as analyzed by 
western blotting. 
Interestingly, inactivation of ATM and ATR in HGPS cells 
partially restored cell-cycle progression into S-phase. This 
confirms that a form of prelamin A (progerin) activated DNA 
damage responses, leading to replicative senescence. 
Importantly, this senescence can be suppressed by inactivating 
DNA damage response pathways in HGPS cells. That only 
partial restoration of S-phase progression is observed is 
probably because of the incomplete repression of the DNA 
damage responses, as even a residual kinase activity could be 
sufficient to enforce a DNA damage checkpoint (Cortez et al., 
2001). Varela et al. showed that p53 knockout completely 
recovered the proliferative capacity of Zmpste24–/– mouse cells 
(Varela et al., 2005). We expect that a highly efficient 
checkpoint inhibition would permit a significant recovery of 
cell division and alleviate many other senescence-associated 
phenotypes in progeroid cells. 
Aberrant nuclear morphology is the most obvious phenotype 
caused by prelamin A accumulation in HGPS and RD 
fibroblasts (Goldman et al., 2004; Toth et al., 2005). Recent 
studies showed that FTI treatment could correct the nuclear 
morphology defects of progeroid cells (Capell et al., 2005; 
Glynn and Glover, 2005; Mallampalli et al., 2005; Toth et al., 
2005). However, we found that FTI treatment could not reduce 
the accumulated DSBs in both HGPS and RD cells. This 
suggests that DNA damage accumulation and misshapen nuclei 
are probably two unrelated phenotypes caused by prelamin A 
accumulation in HGPS and RD. Consistent with this notion, 
p53 knockout can restore proliferative capacity of Zmpste24–/– 
mouse cells, but only partially reverse other disease phenotypes 
(Varela et al., 2005), suggesting that independent pathological 
pathways exist and cooperate with each other in the generation 
of progeroid phenotypes. Thus, strategies for treatment of 
HGPS need to combine elimination of DNA damage 
accumulation as well as normalization of nuclear morphology. 
Materials and Methods 
Cell culture and drug treatments 
Fibroblasts from a HGPS patient with the point mutation 1824CrT were obtained 
from the Coriell Cell Repository (no. AG11513A). Human RD fibroblasts were a 
gift from J. H. Miner (Washington University School of Medicine, St Louis, MO). 
BJ cells and HeLa cells were purchased from American Type Culture Collection 
(ATCC, numbers CRL-2522 and CCL-2, respectively). All cultures were maintained 
in Dulbecco’s modified Eagle’s medium (DMEM) (for RD cells and HeLa cells) or 
Eagle’s minimal essential medium (EMEM) (for HGPS cells and BJ cells) 
supplemented with 10% fetal bovine serum (FBS) and antibiotics (50 units/ml 
penicillin and 50 1g/ml streptomycin) at 37°C under an atmosphere containing 5% 
CO2. For FTI treatment, cells were cultured to 70% confluence, and treated with 5 
1M FTI L-744832 (Biomol, Plymouth Meeting, PA) daily for 72 hours before 
harvest. For the inactivation of ATR and ATM, cells were treated with caffeine at a 
final concentration of 5 mM for at least 2 hours before further analysis. 
Immunofluorescence microscopy 
Cells were grown on coverslips to 70% confluence, washed twice with PBS, and 
then fixed with cold methanol (–20°C) or with 1% formaldehyde followed by 
permeabilization with 0.5% Triton X-100. The fixed cells were blocked with 15% 
FBS, and then incubated with a primary antibody against ATR (rabbit or mouse; 
GeneTex, San Antonio, TX), ATM (mouse; GeneTex), GFP (rabbit; Abcam, 
Cambridge, UK) or y-H2AX (mouse; StressGen Biotechnologies Group, Victoria, 
Canada). After three washes with PBS-1% Tween-20, the cells were incubated with 
a secondary antibody, Alexa Fluor 488-conjugated donkey anti-rabbit 
immunoglobulin G (IgG) or Alexa Fluor 568-conjugated goat anti-mouse IgG 
(Molecular Probes). Nuclei were counterstained with DAPI. Cells were visualized 
by using a Zeiss Axioscope microscope. 
Transfection of plasmids and siRNA 
HeLa cells grown on coverslips were transiently transfected with pEGFP-LAM50 
and pEGFP-LAM50-SSIM plasmid constructs, respectively (both were gifts from 











GeneJammer transfection reagent (Stratagene) following manufacturer’s 
instructions. Twenty-four hours post-transfection, the cells were processed 
differently for the following experiments. For examining the activation of ATM and 
ATR, the cells were irradiated with 20 J/m2 UV or mock treated. Two hours post­
treatment, the cells were processed for immunofluorescence microscopy as 
described above. To measure the amount of y-H2AX, the cells were harvested and 
lysed for western blotting as described below. For detecting the formation of y­
H2AX foci, the cells were fixed with 1% formaldehyde and processed for 
immunofluorescence. 
For the knockdown of ATR and ATM by RNAi, the cells were transfected with 
ATR siRNA and ATM siRNA (Wu et al., 2006), or GFP siRNA as a control using 
TransIT-TKO transfection reagent (Mirus, Madison, WI) following manufacturer’s 
instructions. Further analyses were performed 72 hours after transfection. 
DNA synthesis assay 
DNA synthesis was assayed by the method of thymidine incorporation modified 
from Shao et al. (Shao et al., 1997). Briefly, 2X105 cells were seeded in a 35-mm 
dish 24 hours before pulse-labeling with 0.5 1Ci/ml [methyl-3H] thymidine 
(Amersham Biosciences) for 30 minutes. The cells were then rinsed with PBS three 
times and harvested by lysis with 5% trichloroacetic acid (TCA) at 4°C for 1 hour. 
Cell lysates were subjected to filtering using Whatman glass microfibre filters and 
a vacuum manifold. The filters were washed twice with 5 ml of 5% TCA, once with 
70% ethanol and then dried. The radioactivity of each sample was counted by liquid 
scintillation. 
Western blotting 
Cells cultured in 100-mm dishes were grown to 70% confluence and then 
trypsinized. Cell number was counted by using a hemacytometer. The cells were 
centrifuged at 377 g for 5 minutes and washed twice with PBS. Cell pellet was lysed 
in 2X SDS gel loading buffer and volumes corresponding to 5X106 cells were 
subjected to SDS-PAGE. Immunoblotting was performed as previously described 
(Liu et al., 2005b) with primary antibodies directed against p53 (Santa Cruz), p53 
(ser-15) (Cell Signaling Technology, Beverly, MA), Chk2 (thr-68) (Cell Signaling 
Technology), Chk1 (ser-345) (Santa Cruz), y-H2AX (Bethyl Laboratories, 
Montgomery, TX), GAPDH (Santa Cruz), LaminA/C (Santa Cruz) and [-actin 
(Santa Cruz). The rabbit anti-mouse prelamin A antiserum used was generated 
specifically against the carboxyl-terminal prelamin A and cannot bind mature lamin 
A or lamin C (Sinensky et al., 1994a). 
Comet assay 
The neutral comet assay was performed to assess DNA strand breaks in cells. The 
first layer of agarose on microscope slides was prepared by dipping the slides into 
1% normal melting agarose (NMA) followed by drying. An amount (85 1l) of 0.5% 
low melting agarose (LMA) containing 4X105 cells was made by mixing 10 1l cell 
suspension with 75 1l LMA, and then poured onto the pre-coated slides. Slides 
were immersed in freshly prepared ice-cold buffer (2.5 M NaCl, 100 mM Na2EDTA, 
10 mM Tris-HCl, 1% Triton X-100, pH 10) to lyse the cells for at least 1 hour at 
4°C in the dark. The slides were then placed in the alkaline buffer (0.3 M NaOH, 
1 mM EDTA, pH>13) for 30 minutes for DNA unwinding. The slides were 
equilibrated in Tris-borate-EDTA (TBE) buffer for 5 minutes twice, followed by 
electrophoresis at 1 volt/cm in TBE buffer for 10 minutes. The slides were then 
dipped in 70% ethanol for 5 minutes and dried at room temperature for 1 hour. An 
amount (50 1l) of 600 1M DAPI was used for staining. All steps described above 
were performed under dimmed light to prevent additional DNA damage. The 
quantification of the comets was performed for randomly chosen 50 cells, and DNA 
damage was expressed as the percentage of DNA in tail. 
This study was supported by NCI grant CA86927 (to Y.Z.). 
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